Genetic advances in Type 2 diabetes (T2D) have led to the discovery and validation of multiple markers for this complex disease. Despite low predictive value of current T2D markers beyond clinical ...

A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...

Scientists looked at three measures in the blood: LDL cholesterol; lipoprotein(a), a type of fat; and C-reactive protein, a marker of inflammation. A new approach to a routine blood test could predict ...

NEW YORK, Aug. 31 (UPI) --A single blood test that measures inflammation and fat can predict women's risk for cardiovascular disease 30 years later, a new Harvard study suggests. The findings, ...

Seonix Bio, a leader in the development of genetic testing for glaucoma, today announced the U.S. launch of SightScore, the first commercially available clinical polygenic risk score testing service ...

Experts discuss how knowledge of lipoprotein(a) (Lp[a]) levels can empower patients in managing atherosclerotic cardiovascular disease (ASCVD) risk factors, how providers can collaborate with patients ...

Stress testing results—no matter the modality used to obtain them—predict prognosis among patients with stable, moderate-to-severe CAD, new data from the ISCHEMIA trial suggest. The study, published ...